![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.370, 2002-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Employee influenza vaccination programme worth it in Columbia?
Inpharma, Vol. 1, Iss. 1454, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Employee influenza vaccination programme worth it in Columbia?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 461, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Meningococcal serogroup C vaccination programme well worth it in the UK
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 358, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Influenza vaccination worth it among high-risk children
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 471, 2005-01 ,pp. :